FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/213522 |
Resumo: | Objective: The aim of this study was to evaluate the association of -924 G>A (rs2232365) and -3279 C>A (rs3761548) FOXP3 variants with IBD susceptibility, clinical and endoscopic activity, and IL-10 and TGF-β1 plasma levels. Method: The study included 110 IBD female patients, 60 with Ulcerative Colitis (UC) and 50 with Crohn's Disease (CD), and 154 female controls. FOXP3 variants were determined with Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP). Plasma levels of IL-10 and TGF-β1 were determined using immunofluorimetric assay. Results: AA genotype of rs2232365 and rs3761548 was associated with CD (OR = 3.147, 95% CI 1.015–9.758, p = 0.047) and UC (OR = 3.221, 95% CI 1.050–9.876, p = 0.041) susceptibility, respectively. However, were not associated with TGF-β1 and IL-10 levels, and endoscopic/clinical activity disease. GAGA haplotype was associated with IBD (OR = 4.003, 95% CI 1.100–14.56, p = 0.035) and UC susceptibility (OR = 6.107, 95% CI 1.609–23.18, p = 0.008). In addition, IBD patients with the GAGA haplotype had lower TGF-β1 levels (p = 0.041). Moreover, G/C haplotype (dominant model) had a protective effect of 60% in CD susceptibility and lower Endoscopic Severity Index. Conclusions: These results suggest that FOXP3 variants could exert a role in the Treg, which could be one of the factors involved in the susceptibility and pathogenesis of IBD. |
id |
USP-19_dc0cc63735bf1617f316d40a90b62d9c |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/213522 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel diseaseInflammatory bowel diseasesUlcerative colitisrohn's diseaseForkhead box protein 3 genetic variantsTransforming growth Factor β1Objective: The aim of this study was to evaluate the association of -924 G>A (rs2232365) and -3279 C>A (rs3761548) FOXP3 variants with IBD susceptibility, clinical and endoscopic activity, and IL-10 and TGF-β1 plasma levels. Method: The study included 110 IBD female patients, 60 with Ulcerative Colitis (UC) and 50 with Crohn's Disease (CD), and 154 female controls. FOXP3 variants were determined with Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP). Plasma levels of IL-10 and TGF-β1 were determined using immunofluorimetric assay. Results: AA genotype of rs2232365 and rs3761548 was associated with CD (OR = 3.147, 95% CI 1.015–9.758, p = 0.047) and UC (OR = 3.221, 95% CI 1.050–9.876, p = 0.041) susceptibility, respectively. However, were not associated with TGF-β1 and IL-10 levels, and endoscopic/clinical activity disease. GAGA haplotype was associated with IBD (OR = 4.003, 95% CI 1.100–14.56, p = 0.035) and UC susceptibility (OR = 6.107, 95% CI 1.609–23.18, p = 0.008). In addition, IBD patients with the GAGA haplotype had lower TGF-β1 levels (p = 0.041). Moreover, G/C haplotype (dominant model) had a protective effect of 60% in CD susceptibility and lower Endoscopic Severity Index. Conclusions: These results suggest that FOXP3 variants could exert a role in the Treg, which could be one of the factors involved in the susceptibility and pathogenesis of IBD.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2022-07-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/21352210.1016/j.clinsp.2022.100084Clinics; Vol. 77 (2022); 100084Clinics; v. 77 (2022); 100084Clinics; Vol. 77 (2022); 1000841980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/213522/195618Copyright (c) 2023 Clinicsinfo:eu-repo/semantics/openAccessInoue, Cláudia JunkoFlauzino, TamiresGonçalves, Beatriz PiantoniPaula, Jaqueline Costa Castardo deGalvão, Talita CristinaMiyazaki, Paula KikuchiAlcantara, Camila Cataldi deWestmore, Lucilene Rosa e SilvaLozovoy, Marcell Alysson BatistiReiche, Edna Maria VissociSimão, Andréa Name Colado2023-07-06T13:04:57Zoai:revistas.usp.br:article/213522Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2023-07-06T13:04:57Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease |
title |
FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease |
spellingShingle |
FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease Inoue, Cláudia Junko Inflammatory bowel diseases Ulcerative colitis rohn's disease Forkhead box protein 3 genetic variants Transforming growth Factor β1 |
title_short |
FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease |
title_full |
FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease |
title_fullStr |
FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease |
title_full_unstemmed |
FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease |
title_sort |
FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease |
author |
Inoue, Cláudia Junko |
author_facet |
Inoue, Cláudia Junko Flauzino, Tamires Gonçalves, Beatriz Piantoni Paula, Jaqueline Costa Castardo de Galvão, Talita Cristina Miyazaki, Paula Kikuchi Alcantara, Camila Cataldi de Westmore, Lucilene Rosa e Silva Lozovoy, Marcell Alysson Batisti Reiche, Edna Maria Vissoci Simão, Andréa Name Colado |
author_role |
author |
author2 |
Flauzino, Tamires Gonçalves, Beatriz Piantoni Paula, Jaqueline Costa Castardo de Galvão, Talita Cristina Miyazaki, Paula Kikuchi Alcantara, Camila Cataldi de Westmore, Lucilene Rosa e Silva Lozovoy, Marcell Alysson Batisti Reiche, Edna Maria Vissoci Simão, Andréa Name Colado |
author2_role |
author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Inoue, Cláudia Junko Flauzino, Tamires Gonçalves, Beatriz Piantoni Paula, Jaqueline Costa Castardo de Galvão, Talita Cristina Miyazaki, Paula Kikuchi Alcantara, Camila Cataldi de Westmore, Lucilene Rosa e Silva Lozovoy, Marcell Alysson Batisti Reiche, Edna Maria Vissoci Simão, Andréa Name Colado |
dc.subject.por.fl_str_mv |
Inflammatory bowel diseases Ulcerative colitis rohn's disease Forkhead box protein 3 genetic variants Transforming growth Factor β1 |
topic |
Inflammatory bowel diseases Ulcerative colitis rohn's disease Forkhead box protein 3 genetic variants Transforming growth Factor β1 |
description |
Objective: The aim of this study was to evaluate the association of -924 G>A (rs2232365) and -3279 C>A (rs3761548) FOXP3 variants with IBD susceptibility, clinical and endoscopic activity, and IL-10 and TGF-β1 plasma levels. Method: The study included 110 IBD female patients, 60 with Ulcerative Colitis (UC) and 50 with Crohn's Disease (CD), and 154 female controls. FOXP3 variants were determined with Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP). Plasma levels of IL-10 and TGF-β1 were determined using immunofluorimetric assay. Results: AA genotype of rs2232365 and rs3761548 was associated with CD (OR = 3.147, 95% CI 1.015–9.758, p = 0.047) and UC (OR = 3.221, 95% CI 1.050–9.876, p = 0.041) susceptibility, respectively. However, were not associated with TGF-β1 and IL-10 levels, and endoscopic/clinical activity disease. GAGA haplotype was associated with IBD (OR = 4.003, 95% CI 1.100–14.56, p = 0.035) and UC susceptibility (OR = 6.107, 95% CI 1.609–23.18, p = 0.008). In addition, IBD patients with the GAGA haplotype had lower TGF-β1 levels (p = 0.041). Moreover, G/C haplotype (dominant model) had a protective effect of 60% in CD susceptibility and lower Endoscopic Severity Index. Conclusions: These results suggest that FOXP3 variants could exert a role in the Treg, which could be one of the factors involved in the susceptibility and pathogenesis of IBD. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-07-27 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/213522 10.1016/j.clinsp.2022.100084 |
url |
https://www.revistas.usp.br/clinics/article/view/213522 |
identifier_str_mv |
10.1016/j.clinsp.2022.100084 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/213522/195618 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2023 Clinics info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2023 Clinics |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 77 (2022); 100084 Clinics; v. 77 (2022); 100084 Clinics; Vol. 77 (2022); 100084 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222766663729152 |